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Abstract
A 42 year-old male former semi-professional soccer player sustained a right lower extremity
popliteal contusion during a soccer game. He was clinically diagnosed with a possible traumatic
deep vein thrombosis (DVT), and sent for confirmatory tests. A duplex doppler ultrasound was
positive for DVT, and the patient was admitted to hospital for anticoagulation (unfractionated
heparin, warfarin). Upon discharge from hospital the patient continued oral warfarin
anticoagulation (six months), and the use of compression stockings (nine months). He followed up
with his family doctor at regular intervals for serial coagulation measurements, and ultrasound
examinations. The patient's only identified major thrombotic risk factor was the traumatic injury.
One year after the initial deep vein thrombosis (DVT) the patient returned to contact sport,
however he continued to have intermittent symptoms of right lower leg pain and right knee
effusion.
Athletes can develop vascular injuries in a variety of contact and non-contact sports. Trauma is one
of the most common causes of lower extremity deep vein thrombosis (DVT), however athletic
injuries involving lower extremity traumatic DVT are seldom reported. This diagnosis and the
associated risk factors must be considered during the initial physical examination. The primary
method of radiological diagnosis of lower extremity DVT is a complete bilateral duplex sonography,
which can be augmented by other methods such as evidence-based risk factor analysis.
Antithrombotic medication is the current standard of treatment for DVT. Acute thrombolytic
treatment has demonstrated an improved therapeutic efficacy, and a decrease in post-DVT
symptoms.
There is a lack of scientific literature concerning the return to sport protocol following a DVT
event. Athletic individuals who desire to return to sport after a DVT need to be fully informed
about their treatment and risk of reoccurrence, so that appropriate decisions can be made.

Page 1 of 5
(page number not for citation purposes)

Thrombosis Journal 2004, 2:8

Introduction
Athletes are susceptible to a variety of vascular injuries,
secondary to either repetitive motion, or high-speed collisions [1]. The differential diagnosis for lower extremity
trauma in sport seldom invites a diagnosis of vascular
injury, such as a deep vein thrombosis (DVT). Failure of
the physician to recognize a vascular injury can have catastrophic limb or life threatening (pulmonary embolism)
implications. The epidemiology, diagnosis, treatment,
and recurrence of DVT, as well as the prevention of postthrombotic symptoms are the most current areas of clinical research. Research-based guidelines concerning an athlete's return to sport after a DVT is an important area for
future investigation.

Case Report
A 42 year old Polish born male former semi-professional
soccer player was seen on May 16th, 2003 in the emergency department, with the chief complaint of right leg
pain. The patient had been playing soccer 10 days prior to
this visit, and recalled a traumatic "tackle" injury to the
posterior area of his right lower extremity. He denied
experiencing any sensation of tearing or popping in the
right knee during the index trauma, and was able to complete the game with only minor discomfort. On day 3
post-injury the patient noted severe pain in his knee and
calf with ambulation. The patient visited his primary doctor on post-injury day 8 and was diagnosed with a right
lower extremity soft tissue injury. A right lower extremity
echo-doppler ultrasound (US), and a semi-quantitative
D-dimer automated latex procedure were ordered to rule
out a vascular disorder. The US investigation demonstrated a DVT in the distal femoral, popliteal, and distal
calf veins, with a heterogenous mass (5 cm × 3 cm × 4 cm,
resembling a hematoma) without a doppler signal in the
right popliteal fossa. The D-dimer result was also positive
for a suspected thrombosis (1.0–2.0 ug/ml; range = <0.25
ug/ml). The patient was instructed by his physician to proceed immediately to the emergency department for further evaluation and treatment.
The past medical and family history of the patient was
non-contributory for a history of thrombophilia or other
thrombotic major risk factors. The patient had a remote
(11 years old) surgical history of a right-sided inguinal
hernia that could have created scar tissue contributing to
vascular obstruction and stasis. The initial emergency
department examination demonstrated an exquisitely
tender right calf with a 3 cm difference in mid-calf girth
(10 cm. distal from each inferior patellar pole); a 1+ right
knee supra patellar effusion; and a palpable popliteal
mass with visible ecchymosis. Laboratory tests (CBC,
Lytes, PT, PTT, ESR, CPK, Anti-throbomin, Factor V Leiden, Lupus Screen, ANA, Anti-Cardiolipin, Protein C, and
Protein S) were negative for metabolic, hematological or
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familial abnormalities. A repeat US investigation confirmed the results of the previous outpatient results. The
patient was anticoagulated simultaneously with unfractionated heparin and Warfarin sulfate. A multiview plain
film x-ray examination of the right lower extremity demonstrated no fracture, dislocation, or bony mass.
A magnetic resonance image (MRI) of the right knee was
done several days after admission, to verify a torn right
knee meniscal cartilage that had been previously diagnosed. The official MRI radiological report included a
small free-edge tear of the posterior horn root junction of
the lateral meniscus, chondromalasia (lateral patella and
lateral femoral articular cartilage), and a moderate joint
effusion with a bursal cyst or dilated semimembranousgastronemius bursa.
Anticoagulation was achieved on day 6 of the patient's
hospitalization. He was discharged on 5 mg of warfarin
per day, with instructions to continue the use of compression stockings. The patient was also advised to follow up
with his primary physician for regular monitoring, and to
avoid contact or collision activities during anticoagulation.
The patient was maintained on warfarin for six months,
with weekly physician monitoring (symptoms, PT, INR)
for the first three months post-injury. The monitoring
interval was changed to once per month for the remainder
of the treatment period. Hematologic investigations
(APTT, PT, INR, Cardiolipin antibody, C-reactive protein,
Lupant anticoagulant, Factor V Leiden, Antithrombin,
ANA, Protein C, Protein S, and RPR) were obtained three
months post injury. There were no contributory thrombophilic factors found in these investigations. Laboratory
levels of Protein C activity 22% (range = 70–140%), Protein S activity 48% (range = 75–140%), INR 2.57 (range =
0.88–1.12), and PT 27.5 sec (range = 9.6–12.0 sec); APTT
38.5 sec (range = 23.4–35.4 sec) were found to be appropriately reactive to the anticoagulant therapy.
The patient underwent two arthrocentesis procedures to
remove small amounts of serous fluid from the joint, and
each time was injected with a lidocaine/corticosteroid
combination. US examinations after the hospitalization
period failed to demonstrate a recurrence or new onset of
DVT, however residual echogenic material characteristic
of a chronic thrombus was demonstrated in the popliteal
vein. Compression stocking use was maintained after hospital discharge, and was discontinued after nine months.
The patient returned to soccer after anticoagulation, with
a full understanding of his increased risk of DVT recurrence.
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One-year post injury the patient continued to suffer from
intermittent right lower extremity discomfort and swelling often unrelated to activity. An elective arthroscopy was
recently performed on the patient's right knee to investigate his long-standing meniscal disruption and effusion.
The arthroscopy demonstrated several areas of arthrosis
(patellar lateral and medial facets, lateral and medial femoral condyles), and a torn lateral meniscus. Appropriate
partial lateral menisectomy and debridement, and chondroplasty of the areas of arthrosis were preformed. An
arthroscopic examination of the posterior compartment
demonstrated a small cleft-like area just medial to the
semimembranosis where the Baker's cyst likely originated.
The patient returned to the orthopedist one week post-op
with a large (150 cc's) hemarthrosis that was aspirated
from the knee. He was requested to follow-up in one
month for re-evaluation.

Discussion
This case study illustrates the importance of considering
deep vein thrombosis in the diagnosis of sport-related
extremity trauma. DVT is classically related to venous stasis, intimal injury, and coagulation diathesis (Virchow's
triad). The estimated incidence of DVT from all causes is
0.5 to 1.6 per 1000 persons per year, and may be an
underestimation due to the number of DVT that are
asymptomatic [2].
Standard risk factors for DVT are immobilization, pregnancy, recent surgery (particularly orthopedic), malignancy, older age, smoking, coagulation deficits or
hypercoagulable states, connective tissue disorders, sex
steroid administration, severe dehydration, and major
trauma. Bates et al. [3] presented a table of the estimated
relative risk (RR) for individual DVT risk factors. These
factors include inherited conditions (e.g. Factor V Leiden,
RR = 50, Antithrombin deficiency, RR = 25, Protein C and
S deficiency, RR = 10); acquired conditions (e.g. major
surgery or trauma, RR = 5–200; history of venous thromboembolism, RR = 50); and hereditary, environmental, or
idiopathic conditions (e.g. hyperhomocysteinemia, and
elevated levels of Factor VIII, RR = 3: elevated levels of Factor IX, RR = 2.3).
Coagulation diathesis through congenital or acquired
thrombophilia may promote coagulation [3]. Coagulation deficits in previously healthy athletes are becoming
increasingly identified through laboratory tests, and must
be considered as contributing factors for DVTs [4-7].
Hilberg et al. [6] found that the risk of hereditary exists in
elite athletes, corresponds to the general population.
These authors proposed that countermeasures (e.g. early
anticoagulation during periods of immobilization/injury;
single dose of low molecular weight heparin and/or leg
exercises on long-distance flights; and avoiding hemocon-
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centration with adequate hydration) for athletes who are
carriers of a congenital coagulation deficit [6].
The testing for hypercoagulable states in an individual
after a single episode of thrombosis is a costly, yet routine
procedure in many centers. The common assumption that
an identified presence of a thrombophilic abnormality
increases the risk of recurrence, and justifies prolonged
therapy is without clear supportive evidence. A review of
the current literature concerning the treatment of individuals with coagulation deficits concludes that there is no
clear evidence that modifying treatment because of an
identified hypercoaguable state alters the outcome, or that
more intensive therapy is required in patients with laboratory evidence of thrombophillia [3].
Exercise is thought to act as a protective mechanism
against thrombosis, due to the controlled balance
between the exercise activated coagulation and fibrinolytic pathways [8]. Upper extremity thrombosis that is not
related to primary diseases or well known risk factors are
rare (2–4% of DVTs).This type of thrombosis has been
documented in a variety of sports as effort thrombosis or
"Paget-Schroetter's syndrome" [9-14]. This syndrome is
been described as a primary thrombosis of the subclavicular and axillary veins, usually proceeded by a strenuous
effort or repetitive action involving retroversion and
hyperabuction of the extremity [10]. Vascular compression by adjoining bone, ligament and muscle or resulting
intimal traumas have been documented as contributing
factors toward the development of upper and lower
extremity thrombosis [15-27].
Lower extremity DVT with a traumatic sporting injury in
otherwise healthy active adults is seldom mentioned in
the medical literature [16-29]. This lack of reported cases
of this type of thrombosis may be due to either underreporting or incorrect diagnosis. Very few cases of sportrelated lower extremity DVT involved direct externally
trauma [29,30]. There is one case report (Finnish language) that specifically related DVT development to soccer-related trauma [30], and one case report of lower
extremity DVT in a soccer player with coagulation deficiencies [31]. There is also one case report in the literature
of a traumatic popliteal thrombosis in a hockey player,
which resulted in a fatal pulmonary embolism (PE) [29].
The popliteal, posterior tibial and peroneal veins are susceptible to intimal trauma by the sudden hyperextension
and torsion that the lower extremity experiences in a soccer "kick" or "tackle" motion. The popliteal arteries and
veins are susceptible to direct, sheering, and muscular
compressive forces due to their anatomical position, especially with rapid knee hyperextension or anterior dislocation [13,22].
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The literature demonstrates the importance and efficacy of
a complete bilateral duplex sonography as the primary
method of DVT diagnostic investigation [32]. US findings
can be augmented by other methods (e.g. evidence-based
risk factor analysis) [33,34]. A review of the current literature also suggests the need for comprehensive evidencebased guidelines concerning the use of radiological diagnostic investigations of suspected DVT [35].
Anticoagulation is effective in preventing DVT propagation and PE, but has no chemical fibrinolytic activity. This
type of therapy allows for intrinsic fibrinolysis to occur.
Radiographically demonstrable clot lysis occurs in only
50% of anticoagulated patients, and the incidence of complete resolution is less than 5%. Intrinsic fibrinolysis that
occurs slowly does not preserve the function of the venous
valves, which become fibrotic and fixed after a few weeks
of being trapped in clot [36].
The symptoms experienced by individuals without complete clot resolution include heavy or achy legs, edema,
throbbing paresthesia, purities, numbness, stiffness, and
difficulty standing or ambulating. Postthrombotic syndrome (PTS) is characterized by brawny edema of the leg,
stasis dermatitis, hyperpigmentation, induration, ulceration and chronic leg pain. This syndrome is associated
with an extraordinary level of chronic pain and disability,
and approximately 40% of the total cost of treating DVT is
spent on PTS [36].
Zeigler et al. [37] investigated the long-term clinical outcome of individuals with a first DVT. These authors found
that 82% of the patients suffered from recurrent symptoms, with a mean follow-up period of 6.6 years. Four
level DVT, calf vein thrombosis, recurrence of ipsilateral
DVT, and a non-sufficient oral anticoagulation are of
prognostic significance for developing clinically relevant
symptoms within 10 to 20 years after the first DVT [37].
There is growing evidence that the early lysis provided by
thrombolytic therapy is more likely to preserve valve function, decreasing the likelihood of DVT recurrence, and the
occurrence of PTS [38,39]. Recent trials of new antithrombotic agent used an endpoint of 'symptomatic recurrent
DVT', which was defined as the combination of persistent
or recurrent symptoms along with the radiographic evidence of primary clot progression or new thrombus formation. The rate of symptomatic recurrent DVT was
reported to be between 4–7%, and does not reflect those
individuals who simply continue to be symptomatic after
the primary event [35].
The general knowledge concerning quality of life and burden of illness in patients with persistent post-DVT symptoms is limited. This issue is especially important to the
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athletic patient, as participation in sport is usually an
extremely important component of quality of life. For
routine monitoring of outcomes in chronic venous disorders there are questionnaires that are available [40,41].
Hedner et al. [42] have recently developed an instrument
that measures health and treatment-related quality of life
factors in DVD patients.
The athlete's primary concern upon the initial DVT diagnosis is return to play. The issue of return to sport after a
lower extremity DVTs has only been addressed only once
in the literature concerning return to non-contact sport
[43]. General guidelines for sedentary individuals allow
for a gradual return to return to daily activities over a six
week period [43], with no contact activities allowed during the period of anticoagulation. Roberts and Christie
[43] provided a theoretical framework, based on the natural history of animal models for the safe and expeditious
return of the athlete. These authors suggested a protocol
that combines a graduated return to activity and anticoagulation therapy with regular physician based reevaluation
[43].
An athlete who wants to return to a contact or collision
sport should be informed of the possible increased risk of
recurrent DVT that he or she may face, above the current
estimates derived from the general population. There is
no current evidence in the literature that investigates the
specific risk factor of a traumatic collision, and the recurrence of a DVT. This lack of evidence suggests that the
patient and physician should work together to make an
informed return to play decision involving the patient's
current individual risk profile, the likelihood of DVT
recurrence, athletic goals, and the perceived importance of
the particular sport to quality of life.
The potential limitations of this case study include the
lack of testing for prothrobin mutation, and fibrynolitic
parameters (level of tPA, PAI-1 or PAI-1 polymorphism
4G/5G).
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